{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:53Z","timestamp":1790758613835,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.brachy.2014.12.007","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T09:41:36Z","timestamp":1423561296000},"page":"366-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis"],"prefix":"10.1016","volume":"14","author":[{"given":"Robyn","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-June","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Jeffrey","family":"Demanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Kamrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2014.12.007_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2217\/fon.11.51","article-title":"Evolution from active surveillance to focal therapy in the management of prostate cancer","volume":"7","author":"Lindner","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.brachy.2014.12.007_bib2","doi-asserted-by":"crossref","first-page":"587139","DOI":"10.1155\/2012\/587139","article-title":"The role of targeted focal therapy in the management of low-risk prostate cancer: Update on current challenges","volume":"2012","author":"Smith","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.brachy.2014.12.007_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2014.12.007_bib4","series-title":"Radiotherapy in Prostate Cancer","first-page":"173","article-title":"Focal therapy and the index lesion hypothesis in prostate cancer","author":"Kamrava","year":"2015"},{"key":"10.1016\/j.brachy.2014.12.007_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.brachy.2012.09.002","article-title":"Focal high-dose-rate brachytherapy: A dosimetric comparison of hemigland vs. conventional whole-gland treatment","volume":"12","author":"Kamrava","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/pros.21347","article-title":"High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer","volume":"71","author":"Schick","year":"2011","journal-title":"Prostate"},{"issue":"Suppl. 1","key":"10.1016\/j.brachy.2014.12.007_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.2011.10825.x","article-title":"Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer","volume":"109","author":"Langley","year":"2012","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.brachy.2014.12.007_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.brachy.2014.06.007","article-title":"Dosimetry modeling for focal high-dose-rate prostate brachytherapy","volume":"13","author":"Mason","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.brachy.2014.01.011","article-title":"Multiparametric MRI identifies and stratifies prostate cancer lesions: Implications for targeting intraprostatic targets","volume":"13","author":"Anderson","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.radonc.2013.12.003","article-title":"Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: Quantitative analysis of imaging contour compared to whole-mount histopathology","volume":"110","author":"Anwar","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2014.12.007_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American brachytherapy society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.12.007_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2006.03.004","article-title":"Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer","volume":"5","author":"Yamada","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijrobp.2010.04.046","article-title":"Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer","volume":"80","author":"Morton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.12.007_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2005.02.015","volume":"63","author":"Akimoto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.12.007_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1748-717X-9-122","article-title":"Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer","volume":"9","author":"Ghadjar","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2014.12.007_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prro.2013.02.011","article-title":"Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dose","volume":"4","author":"Hsu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2014.12.007_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brachy.2013.02.002","article-title":"Focal brachytherapy for selected low-risk prostate cancers: A pilot study","volume":"12","author":"Cosset","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib19","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ijrobp.2010.09.006","article-title":"High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A phase II trial","volume":"82","author":"Barkati","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.12.007_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijrobp.2010.12.029","article-title":"Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy","volume":"82","author":"Georg","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.12.007_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2012.07.004","article-title":"High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: Treatment evolution and mature results","volume":"85","author":"Zamboglou","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.12.007_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.juro.2007.03.140","article-title":"Erectile function outcome reporting after clinically localized prostate cancer treatment","volume":"178","author":"Burnett","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2014.12.007_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brachy.2013.10.006","article-title":"An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer","volume":"13","author":"Marina","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.12.007_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2012.11.057","article-title":"Morbidity of focal therapy in the treatment of localized prostate cancer","volume":"63","author":"Barret","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2014.12.007_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2014.12.007_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2014.06.013","article-title":"Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life","volume":"112","author":"Peters","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:08:50Z","timestamp":1761530930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472115000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1538472115000021"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2014.12.007","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}